Showing results (91-100 of 283) with videos related to
Sort By:
Pageof 29
BJU International|July 6, 2013
The utility of prostate-specific antigen in the management of advanced prostate cancerE David Crawford, Charles L Bennett, Gerald L Andriole, et al.Cancer Treatment and Research|November 30, 2022
Maximum Accuracy Machine Learning Statistical Analysis-A Novel ApproachShannon Ugarte, Paul Yarnold, Paul Ray, et al.Pharmacotherapy|October 10, 2019
Hepatitis B Virus Reactivation: Risk Factors and Current Management StrategiesDanielle J Smalls, Reagan E Kiger, LeAnn B Norris, et al.Gynecologic Oncology|March 30, 2004
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physiciansElizabeth A Calhoun, David A Fishman, John R Lurain, et al.Archives of Internal Medicine|May 25, 2005
High rates of adverse drug events in a highly computerized hospitalJonathan R Nebeker, Jennifer M Hoffman, Charlene R Weir, et al.The Journal of Community and Supportive Oncology|February 27, 2016
Joint breast and colorectal cancer screenings in medically underserved womenTerry C Davis, Connie L Arnold, Michael S Wolf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizationsCharles L Bennett, Mark R Somerfield, David G Pfister, et al.Archives of Internal Medicine|March 26, 2008
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006Benjamin Djulbegovic, Ambuj Kumar, Heloisa P Soares, et al.Journal of Women'S Health (2002)|February 19, 2015
Sustaining mammography screening among the medically underserved: a follow-up evaluationTerry C Davis, Connie L Arnold, Charles L Bennett, et al.Archives of Internal Medicine|September 15, 2010
Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agentsCharles L Bennett, Stephen Y Lai, Michael Henke, et al.Pageof 29